AMN Healthcare 服务 AMN

Ms. Grace brings to the Board more than three decades of experience developing and executing profitable growth strategies for leading professional and financial services organizations across human capital, banking, investments, health, and mergers and acquisitions. Prior to her tenure at AMN Healthcare, Ms. Grace was most recently at Aon, a leading global professional services firm providing risk, health and wealth solutions, where she led Aon's Global Retirement, Investment and Human Capital business line, as well as the Global M&A integration and Enterprise Client Management functions. While at Aon, Ms. Grace served on its Policy and Governance Team, served on the Operating Committee and was a named executive officer of the corporation. Ms. Grace's extensive experience in leading large market-driven businesses with a focus on digital enablement provides valuable insight and leadership as the Company continues to evolve and develop technology-related and enabled solutions for clients and healthcare professionals. Ms. Grace has been recognized for her leadership, being named Modern Healthcare's 100 Most Influential Healthcare Leaders in 2025 and prior years being named as one of the Most Powerful Women in Finance by American Banker. Board Experience: State Farm Mutual, the largest property and casualty insurance company offering auto, home, life and health insurance as well as investment services, where she serves as Chair of the Finance and Investment Committee (2022-present); League, Inc., a privately held digital platform and technology company empowering consumer health engagement (2020-present); FinTech Evolution Acquisition Group, where she served as Chair of the Audit Committee (2021-March 2023); Rush University Medical Center Board of Trustees (2020-present); Georgetown University Board of Directors (2025-present). Qualification Highlights: President and CEO of AMN Healthcare Services, Inc. (November 2022-present); Chief Executive Officer of the Global Retirement, Investment and Human Capital Solutions business at Aon PLC (2016-January 2020); Various Executive Leadership Positions within Aon, including CEO of Aon Health Exchanges (2012-2019); Bank of America, where she led several institutional and private banking businesses, including their 9 billion Mass Affluent Client Business (1998-2012). First Chicago Bank & Trust, a predecessor to JP Morgan Chase & Co., where she served in several roles including head of Investor Relations (1990-1998).

Mark Hagan joined us as Chief Information Officer in June 2018. In March 2020, Mr. Hagan was promoted to Chief Information and Digital Officer and is responsible for our digital strategy, technology R&D, enterprise information technology infrastructure, operations, development, security, and program management operations. Prior to joining AMN, from 2014-2018, Mr. Hagan was Chief Information Officer and Senior Vice President of IT at Envision Healthcare, a diverse healthcare services and technology company and a leading provider of physician-led services, post-acute care, ambulatory surgery services, and related management services. Prior to Envision, Mr. Hagan was IT Director at TeleTech. Mr. Hagan currently serves as a director of M&M Properties Colorado LLC and Wonolo, Inc. Mr. Hagan holds a Master of Business Administration from the University of Colorado, a Bachelor of Science and Computing from Queensland University of Technology.

On October 3, 2024, AMN Healthcare Services, Inc. announced that Brian Scott will join AMN as its Chief Financial Officer and Chief Operating Officer. Mr. Scott will join the AMN leadership team and assume the responsibilities of CFO/COO on November 21, 2024. Mr. Scott's appointment follows the recent announcement by the Company effective November 8, 2024. In his role as CFO/COO, Mr. Scott, will be responsible for AMN's finance and enterprise operating functions. Mr. Scott is returning to AMN, having previously served as the Company's Chief Financial Officer and Chief Accounting Officer, from 2011 to 2021. Immediately prior to re-joining AMN, Mr. Scott served as Chief Financial Officer of Jack in the Box, Inc., a franchisor in the quick-service restaurant industry, since August 2023. Previously, he served as Chief Financial Officer of ShiftKey, a leading digital platform connecting independent, licensed healthcare professionals with open shifts at healthcare facilities in the U.S., from June 2023 to August 2023, and as ShiftKey's Chief Strategy Officer from September 2022 to June 2023. Mr. Scott also served as Chief Financial Officer of TheKey, a provider of home care services, from August 2021 to August 2022. Mr. Scott first joined AMN in 2003, and served in a variety of roles of increasing responsibility in finance and accounting roles over a 17-year career with the Company. He received a Bachelor's degree in accounting and finance from California Polytechnic State University-San Luis Obispo, and a Master of Business Administration from the McCombs School of Business at the University of Texas at Austin.

Ms. Laughlin joined us in 2006 and was named Deputy General Counsel in 2011. In August 2023, Ms. Laughlin was promoted to Chief Legal Officer and Corporate Secretary. Ms. Laughlin is responsible for overseeing our legal, corporate governance, environmental, social and governance functions, privacy and compliance, government and community affairs and equity compensation. She currently serves on the Executive Committee of the Board of SafeHaven of Tarrant County and on the Board of International Esperanza Project. Prior to joining AMN Healthcare, Ms. Laughlin was a partner at Lewis, Brisbois, Bisgaard and Smith where she had an employment litigation practice, primarily serving healthcare and staffing industry clients. She received her law degree from Georgetown University Law Center and a Bachelor of Science in Political Science and a Bachelor of Arts in Communications, both from Southern Methodist University. Ms. Laughlin is a licensed attorney in California and Texas.

Mr. Caballero brings to the Board significant public company accounting and financial reporting expertise and a top-level perspective in organizational management. Mr. Caballero's career has provided him with practical knowledge of executive management of complex, global businesses and extensive experience in a wide range of financial and accounting matters including management of global financial operations, financial oversight, risk management and the alignment of financial and strategic initiatives. Mr. Caballero also brings deep corporate governance experience through his work with public and private companies and in his board leadership positions at Deloitte and extensive experience in mergers and acquisitions, a critical component to the Company's growth strategy. The Board has determined that Mr. Caballero qualifies as an audit committee financial expert and has appointed him to the Audit Committee. Mr. Caballero serves as the Chair of the Corporate Governance and Compliance Committee. Board Experience: Deloitte Tax LLP, a global professional services firm and one of the Big Four accounting firms, where he was the Chief Diversity Officer (2009-2016); United Way of Essex and West Hudson in New Jersey, a non-profit organization where he served as the chair of Board of Directors and Finance Committee (2003-2019); The College of New Jersey, where he served as the chair of the Board of Directors, Finance Committee, and Audit and Risk Management Committee (2007-2019); Jersey Battered Women's Service, a private, non-profit agency, where he served as the chair of the Finance, Human Resources, and Infrastructure Committees (1993-2001). Qualification: Managing Partner of Deloitte's Business Tax Services U.S.-India practice (2016-2019); New Jersey Tax Managing Partner of Deloitte (2003-2011); Assistant Vice President of Tax of Beneficial Corporation, a consumer finance company that was acquired by Household International, Inc. in 1998 (1983-1986).

Mr. Foletta brings to the Board considerable audit, financial, healthcare and enterprise risk management experience as both an executive officer and director of healthcare companies and has significant experience serving the Company under different operating environments, management teams, and market cycles strengthening the Board's perspective and capabilities. Mr. Foletta's prior experience as a public company CFO provides the Board with extensive public company accounting and financial reporting expertise to guide the Company's commitment to strong financial discipline, effective allocation of capital and accurate disclosure practices. Mr. Foletta assisted with developing and launching the initial enterprise risk management assessment at Amylin Pharmaceuticals and guided the launch of the initial risk management assessment at both Regulus and DexCom. Career highlights: Mr. Foletta, Executive Vice President and Chief Financial Officer of Tocagen Inc., a brain cancer biotechnology company, from February 2017 until its acquisition by Forte Biosciences, Inc. in March 2020 ; Interim Chief Financial Officer of Biocept, Inc., a publicly traded diagnostics company (August 2015 to July 2016) ; Senior Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc. (March 2006 - October 2012) ; Vice President, Finance and Chief Financial Officer of Amylin (March 2000 - March 2006) ; Certified Public Accountant (inactive) and a member of the Corporate Directors Forum ; Assisted with developing and launching the initial enterprise risk management assessment at Amylin Pharmaceuticals and guided the launch of the initial risk management assessment at both Regulus and DexCom Board Experience ; DexCom, Inc., a publicly traded diabetes care technology company, since November 2014, where he is the Lead Independent Director ; Enanta Pharmaceuticals, a publicly traded biotechnology company, where he is the Chair of the Audit Committee (June 2020 - present) ; Regulus Therapeutics Inc., where he served as Chair of the Audit Committee and a member of the Nominating and Governance Committee (February 2013 - June 2018) ; Viacyte, Inc., a privately held company ; Ambit Biosciences Corporation, where he served as Chair of the Audit Committee (sold in 2014) ; Anadys Pharmaceuticals, Inc. (sold in 2011).

Ms. Jones brings to the Board considerable information technology, global digital technology use, data management and privacy experience as a seasoned C-Suite executive with extensive experience in multinational corporations. Ms. Jones' digital use and technology expertise and experience provides valuable insights in leading innovative change, technological advancement and strategic growth and is critical to our successful execution of our technology and digital strategies. Ms. Jones, Senior Vice President, Digital/Future of Work for GE Healthcare, the healthcare business of GE (May 2017 - October 2017) ; Senior Vice President, Chief Information Officer for GE Healthcare Diagnostic Imaging and Services (August 2014 - May 2017) ; Senior Vice President, Chief Information Officer for Hospira, Inc., a provider of pharmaceuticals and infusion technologies (October 2009 - June 2014) ; Chief Information Officer at Johnson & Johnson (2006 to 2009); served in various information technology roles with Johnson & Johnson (1997 - 2006) ; Founder, The Board Curators, LLC (July 2021 -present) ; Founder, Destiny Transformations Group, LLC (April 2018 - present) Board Experience ; Masonite International Corp., a publicly traded global designer, manufacturer, and distributor of internal and external doors for the construction and renovation industry, where she serves as a member of the Corporate Governance and Nominating Committee (February 2018 - present) ; Barnes Group Inc., a publicly traded engineered products and industrial technologies company, where she serves on the Audit Committee (September 2019 - present) ; Thurgood Marshall College Fund, a not-for-profit organization and the nation's largest organization exclusively representing the Black College Community.

Dr. Trent-Adams' experience as a C-Suite healthcare leader and clinician provides the Board with valuable insights as the Company continues to evolve to serve the more diverse needs of our clients, clinicians and the complexities of large growing health systems and to proactively anticipate their needs driven by changes in care delivery, reimbursement, and other factors. Dr. Trent-Adams' experience serving in high levels of the federal government health service and understanding of the drivers and development of public policy enhances the Board's ability to provide effective oversight of clinical quality, government policy and regulatory risk, all of which are critical to the successful design and implementation of our growth strategy. Career Highlights: President, University of North Texas Health Science Center at Fort Worth (September 2022-January 2025); Executive Vice President and Chief Strategy Officer of the University of North Texas Health Science Center at Fort Worth (October 2020-September 2022); Served in the U.S. Public Health Service Commissioned Corps, including service as Deputy Surgeon General and Acting Surgeon General of the United States (1992-2020); Held leadership roles in the U.S. Department of Health and Human Services, including as Principal Deputy Assistant Secretary for Health (January 2019-September 2020). Board Experience: University of Minnesota School of Nursing, Board of Visitors (2020-2023); Institute for Healthcare Improvement, an independent not-for-profit organization, focused on advancing and sustaining better outcomes in health and healthcare (2022-present); One Safe Place, a non-profit organization (2022-present)

Mr. Hinton brings broad-based leadership experience in the healthcare industry, including governance, compliance and operational expertise, serving both as a CEO of large health systems and director of a publicly traded healthcare company. Mr. Hinton's deep understanding of healthcare systems' challenges and opportunities provides valuable insights to direct our strategy and innovate to provide enhanced and expanded talent solutions service offerings to meet our clients' evolving needs. Mr. Hinton also brings to the Board experience in development of integrated systems and healthcare mergers and acquisitions. Board Experience: McKesson Corporation, a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology (2022-present); American Hospital Association Board of Trustees, the national organization that represents over 5,000 hospital and health care networks, where he served as a Chair (2014) and Trustee (2011-2016). Qualification Highlights: Operating Partner with Welsh Carson Anderson Stowe (WCAS) (2022-present); CEO of Baylor Scott & White Health (2017-2021); President and CEO of Presbyterian Healthcare Services (1995-2016); Vice President and Chief Operating Officer (1992-1995); Executive Director (1987-1992); Director of Business Development (1987-1992).

Ms. Huber is a senior partner at McKinsey & Company, where she leads the North American board services practice and advises publicly-traded, not-for-profit and public-sector healthcare organizations, including non-profit and publicly-traded health insurers, benefits administrators, health systems and providers, and public sector payors, on strategies within a context of industry and regulatory change. Ms. Huber has significant experience advising on healthcare strategy, as well as governance, board effectiveness, creation of innovative partnerships, and supporting new operating models. Ms. Huber is a core leader of McKinsey's leadership forums, leads the McKinsey & Company West Coast healthcare CEO roundtable, and serves as the Chief Risk Officer for McKinsey in North America. Board Experience: AltaMed Foundation, a non-profit organization that serves as the fundraising arm for AltaMed Health Services, a community health center in Southern California, with the goal of increasing access to quality healthcare and reducing health disparities within the community (2021-present); California Business Roundtable, a nonpartisan organization that provides a platform among executives for collaboration and advocacy on issues critical to California's economic health, where she is a member of the Executive Committee (2017-present); Citizens United for Research in Epilepsy (CURE), a non-profit dedicated to finding a cure for epilepsy by raising funds for research and by increasing awareness (2016-2021); Make-A-Wish Greater Pennsylvania and West Virginia (Vice Chair), a non-profit organization dedicated to creating life-changing wishes for children with critical illnesses (2002-2009). Qualification Highlights: Senior Partner, McKinsey and Company (2009-Present), Partner (2002-2009), Consultant (1992-2002).